Clinical Trial Update: Dose Dense Doxorubucin and Cyclophosphamide Followed by Eribulin Mesylate for the Adjuvant Treatment of Early Stage Breast Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating dose-dense doxorubicin and cyclophosphamide followed by eribulin for adjuvant treatment of early-stage breast cancer completed with pos…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• CYCLOPHOSPHAMIDE (Cyclophosphamide)
• Doxorubicin (doxorubicin)
• ERIBULIN MESYLATE (Eribulin mesylate)

Snippet

Sponsor: Eisai Inc. | Conditions: HER2-normal | Phase 2 | Status: COMPLETED | Results posted: 2018-09-26